0001209191-15-002245.txt : 20150106
0001209191-15-002245.hdr.sgml : 20150106
20150106164521
ACCESSION NUMBER: 0001209191-15-002245
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150102
FILED AS OF DATE: 20150106
DATE AS OF CHANGE: 20150106
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Chodakewitz Jeffrey
CENTRAL INDEX KEY: 0001610876
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 15510579
MAIL ADDRESS:
STREET 1: C/O TETRAPHASE PHARMACEUTICALS, INC.
STREET 2: 480 ARSENAL ST., SUITE 101
CITY: WATERTOWN
STATE: MA
ZIP: 02472
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-01-02
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001610876
Chodakewitz Jeffrey
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
0
1
0
0
EVP GMDA, CMO
Common Stock
2015-01-02
4
M
0
2291
73.51
A
86791
D
Common Stock
2015-01-02
4
S
0
100
119.03
D
86691
D
Common Stock
2015-01-02
4
S
0
1200
122.35
D
85491
D
Common Stock
2015-01-02
4
S
0
991
123.12
D
84500
D
Stock Option (right to buy)
73.51
2015-01-02
4
M
0
2291
0.00
D
2024-01-01
Common Stock
2291
45835
D
Transaction made pursuant to Dr. Chodakewitz's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $122.35 (range $121.75 to $122.74).
Dr. Chodakewitz undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $123.12 (range $122.78 to $123.33).
The option vests in 16 quarterly installments from 01/02/2014.
Kenneth L. Horton, Attorney-In-Fact
2015-01-06